Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

FDA accepts filing of Medicines Co's US biologic license application for fibrocaps hemostatic agent


Thursday, 3 Apr 2014 07:00am EDT 

Medicines Co:Says that the U.S. Food and Drug Administration (FDA) has accepted the filing of a biologic license application (BLA) for the investigational hemostatic agent Fibrocaps, a dry powder formulation of fibrinogen and thrombin. 

Company Quote

21.99
 --
23 Oct 2014